Dale Broadrick serves as Executive at BioRestorative Therapies, Inc., where they oversee executive responsibilities. Since joining the company, Dale Broadrick has executed 109 insider transactions totaling $3.2M, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 22, 2019 involved purchasing 39,985 shares valued at $25.6K.
Dale Broadrick currently holds 477,972 shares of BioRestorative Therapies, Inc. (BRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dale Broadrick has been a net buyer of BRTX stock. They have purchased $3.2M and sold $7.9K worth of shares.
Dale Broadrick's most recent insider trade was on Apr 22, 2019, when they purchased 39,985 shares at $0.64 per share.
Get notified when new Form 4 filings are submitted
| $0.63 |
| Discretionary |
| Apr 9, 2019 | BRTX | $85 | Purchase | 100 | $0.85 | Discretionary |
| Apr 8, 2019 | BRTX | $182 | Purchase | 200 | $0.91 | Discretionary |
| Apr 4, 2019 | BRTX | $2.0K | Purchase | 2,500 | $0.80 | Discretionary |
| Mar 13, 2019 | BRTX | $1.9K | Purchase | 3,000 | $0.65 | Discretionary |
| Mar 5, 2019 | BRTX | $4.1K | Purchase | 6,000 | $0.69 | Discretionary |
| Feb 27, 2019 | BRTX | $270 | Purchase | 409 | $0.66 | Discretionary |
| Feb 26, 2019 | BRTX | $680 | Purchase | 1,000 | $0.68 | Discretionary |